Showing 1621-1630 of 2742 results for "".
- Dermalogica Enters Device Market With FDA-Cleared Microneedling Systemhttps://modernaesthetics.com/news/dermalogica-enters-device-market-with-fda-cleared-microneedling-system/2486887/Dermalogica has announced the launch of its PRO Pen Microneedling System following US Food and Drug Administration (FDA) 510(k) clearance, marking the company’s first entry into the medical device category. The device is indicated for the treatment of facial acne scars in adults aged 22 years and
- 12-Month Data Support Durability of Click-Crosslinked HA for Nasolabial Foldhttps://modernaesthetics.com/news/12-month-data-support-durability-of-click-crosslinked-ha-for-nasolabial-fold/2486822/A novel long-chain hyaluronic acid (HA) filler utilizing click-chemistry crosslinking demonstrated sustained efficacy and a favorable safety profile for nasolabial fold (NLF) correction in 2 prospective studies published in the Journal of Cosmetic Dermatology. Traditional HA fille
- Revance Highlights RHA Dynamic Volume Mid-Face FDA Approval at Virtual Desk Sidehttps://modernaesthetics.com/news/revance-highlights-rha-dynamic-volume-mid-face-fda-approval-at-virtual-desk-side/2486819/Revance Aesthetics hosted a virtual desk side with Lesley Clark-Loeser, MD, to discuss the recent US Food and Drug Administration (FDA) approval of RHA Dynamic Volume for cheek augmentation and correction of age-related mid-face contour deficiencies in adults aged 22 years and older. The a
- SkinCeuticals Launches Future Mineral UV Defense SPF 50 for Daily and Post-Procedure Usehttps://modernaesthetics.com/news/skinceuticals-launches-future-mineral-uv-defense-spf-50-for-daily-and-post-procedure-use/2486804/SkinCeuticals has introduced Future Mineral UV Defense SPF 50, a new mineral sunscreen designed to provide broad-spectrum UV protection while also addressing visible signs of skin aging, according to the company. The formulation combines 15% zinc oxide and 3% titanium dioxide and is intend
- Interim IIT Data Explore Sculptra, Restylane for Menopause, Weight Loss–Related Aesthetic Changeshttps://modernaesthetics.com/news/interim-iit-data-explore-sculptra-restylane-for-menopause-weight-lossrelated-aesthetic-changes/2486595/Interim findings from 2 ongoing investigator-initiated trials supported by Galderma suggest potential roles for Sculptra and the Restylane portfolio in treating aesthetic changes associated with menopause and medication-driven weight loss. In one interim analysis led by Sabrina Fabi, MD, 2
- Merz Aesthetics Secures FDA Approval for RADIESSE in Décolleté Treatmenthttps://modernaesthetics.com/news/merz-aesthetics-secures-fda-approval-for-radiesse-in-decollete-treatment/2486550/Merz Aesthetics has received US Food and Drug Administration (FDA) approval for RADIESSE® (calcium hydroxylapatite [CaHA]) for the treatment of moderate to severe wrinkles in the décolleté in adults aged 22 years and older, according to a company announcement. The decision expands the
- Paper: AI Gains Ground in Cosmetic Dermatology Workflowshttps://modernaesthetics.com/news/paper-ai-gains-ground-in-cosmetic-dermatology-workflows/2486551/A recent review in Dermatology and Therapy assessed the growing use of artificial intelligence (AI) across aesthetic dermatology, with the authors reporting increased adoption and highlighting its use in many aspects of prac
- New Data Highlight How Ultrasound Imaging May Improve Safety in High-Risk Filler Injectionshttps://modernaesthetics.com/news/new-data-highlights-how-ultrasound-imaging-may-improve-safety-in-high-risk-filler-injections/2486532/The use of dermal fillers continues to expand across aesthetic practice, accompanied by ongoing concerns regarding vascular adverse events (VAEs), including tissue necrosis and vision loss. In a recent publication in Aesthetic Plastic Surgery, investigators evaluated the role of high-res
- Case Report Describes Dual-Phase CL Code for Facial Rejuvenationhttps://modernaesthetics.com/news/case-report-describes-dual-phase-cl-code-for-facial-rejuvenation/2486484/A case report in the April 2026 issue of Journal of Cosmetic Dermatology described a dual-phase injectable approach to facial rejuvenation that combined contour restoration with ligamentous support using a polycaprolactone-based collagen stimulator. The authors termed the method the “CL
- AAD 2026: New Study Highlights Dual-Action Antioxidant Serum for UV-Induced Skin Protectionhttps://modernaesthetics.com/news/aad-2026-new-study-highlights-dual-action-antioxidant-serum-for-uv-induced-skin-protection/2486463/New research presented at the 2026 American Academy of Dermatology (AAD) Annual Meeting highlights the potential of a multifunctional antioxidant serum, AOX2.0, to protect human skin from ultraviolet (UV)-induced damage while supporting epidermal recovery. The study examined how oxidative stress